LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$81.30 USD
+0.11 (0.14%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $81.00 -0.30 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum C VGM
Brokerage Reports
LeMaitre Vascular, Inc. [LMAT]
Reports for Purchase
Showing records 101 - 120 ( 191 total )
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
3Q19 Recap - Solid Results; Waiting on Entry Point
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
2Q19 Recap - Upside Results Appear Priced In (Pending Acquisitions)
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
1Q19 Recap - Acquisitions Appear the Near-Term Driver
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are placing shares Under Review, and transferring coverage to due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
We are transferring coverage, placing Under Review, and removing PT''s and estimates
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Transferring coverage with a Neutral rating, $39/share price target
Provider: Roth Capital Partners, Inc.
Analyst: SOLOMON D
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
2Q18 Recap - In Line Quarter, Near- Term Acquisition?
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: LeMaitre Vascular, Inc.
Industry: Medical - Products
Growth Story Intact; Resuming with a Buy Rating, $38 PT
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S